Sirtuin-1 In Hypertension: Linking Oxidative Stress And Mitochondrial Dysfunction To Vascular Aging And Therapeutic Potential
High blood pressure, also known as hypertension, is a widespread health issue characterized by several damaging processes within the body, including an imbalance between harmful molecules and protective antioxidants (called oxidative stress), problems with the cell’s energy factories (mitochondrial dysfunction), and accelerated aging of blood vessels. These factors collectively contribute to the damage seen in organs affected by high blood pressure.
Emerging research highlights the importance of a protein called Sirtuin-1 (SIRT1) in maintaining the health of our blood vessels and overall body balance. SIRT1 acts like a master switch, influencing various cellular activities.
Studies suggest that by modulating SIRT1 activity, it might be possible to improve how blood vessels function, restore proper mitochondrial activity, reduce oxidative stress and inflammation, and lessen the structural changes that occur in blood vessels. These improvements could potentially limit organ damage associated with high blood pressure.
While experimental findings are promising, showing that targeting SIRT1 can have protective effects in various models of cardiovascular disease, the impact on actual blood pressure levels has been less consistent and seems to depend on the specific experimental conditions.
Currently, clinical evidence in humans is still limited, although some studies have observed altered SIRT1 levels or activity in individuals with high blood pressure. More extensive and well-designed clinical trials are needed to fully understand if modulating SIRT1 can truly improve long-term cardiovascular health outcomes and to establish its value as a potential indicator of disease or a target for new therapies.
Source: link to paper